Near-infrared light stimuli-responsive synergistic therapy nanoplatforms based on the coordination of tellurium-containing block polymer and cisplatin for cancer treatment

Biomaterials

Volumn 133, Issue , 2017, Pages 208-218

  Li, Feng ^a   Li, Tianyu ^a   Cao, Wei ^a   Wang, Lu ^a   Xu, Huaping ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Cancer treatment; Cisplatin; Coordination chemistry; Drug delivery; Photo responsive; Tellurium containing polymer

Indexed keywords

BLOCK COPOLYMERS; CHEMICAL BONDS; CHEMOTHERAPY; COORDINATION REACTIONS; DISEASES; DRUG DELIVERY; DRUG PRODUCTS; DRUG THERAPY; ELECTRONEGATIVITY; ENCAPSULATION; ENZYME INHIBITION; FUNCTIONAL POLYMERS; INFRARED DEVICES; INFRARED LASERS; IRRADIATION; MOLECULES; ONCOLOGY; OXIDATION; PLASMA STABILITY; PLATINUM COMPOUNDS; POLYMERS; TELLURIUM COMPOUNDS;

CIS-PLATIN; CO-ORDINATION CHEMISTRIES; COORDINATION INTERACTIONS; DRUG DELIVERY SYSTEM; DRUG RELEASE PROPERTIES; ENCAPSULATION EFFICIENCY; NEAR-INFRARED LASERS; PHOTO-RESPONSIVE;

TELLURIUM;

CISPLATIN; COPOLYMER; INDOCYANINE GREEN; MONOMER; NANOCARRIER; PLATINUM; POLYMER; REACTIVE OXYGEN METABOLITE; TELLURIUM; ANTINEOPLASTIC AGENT; DRUG CARRIER; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER THERAPY; CELL VIABILITY; CELLULAR DISTRIBUTION; CIRCULATION TIME; COMPLEX FORMATION; CONFOCAL MICROSCOPY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; EX VIVO STUDY; FEMALE; FLUORESCENCE; FLUORESCENCE IMAGING; FLUORESCENCE SPECTROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYDRODYNAMICS; IN VITRO STUDY; IN VIVO STUDY; LASER; LOW LEVEL LASER THERAPY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; OXIDATION; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SYNTHESIS; THERMOTHERAPY; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; X RAY PHOTOELECTRON SPECTROSCOPY; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DRUG SCREENING; EXPERIMENTAL MAMMARY NEOPLASM; INFRARED RADIATION; METABOLISM; PROCEDURES; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CISPLATIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; INDOCYANINE GREEN; INFRARED RAYS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE, INBRED BALB C; NANOPARTICLES; POLYMERS; REACTIVE OXYGEN SPECIES; TELLURIUM; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85018467220     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2017.04.032     Document Type: Article

References (44)

1. [1] Abu-Surrah, A.S., Kettunen, M., Platinum group antitumor chemistry: design and development of new anticancer drugs complementary to cisplatin. Curr. Med. Chem. 13 (2006), 1337–1357.
2. [2] Kelland, L., The resurgence of platinum-based cancer chemotherapy. Nat. Rev. Cancer 7 (2007), 573–584.
3. [3] Liang, X.J., Meng, H., Wang, Y., He, H., Meng, J., Lu, J., Wang, P.C., Zhao, Y., Gao, X., Sun, B., Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis. Proc. Natl. Acad. Sci. U.S.A. 107 (2010), 7449–7454.
4. [4] Go, R.S., Adjei, A.A., Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J. Clin. Oncol. 17 (1999), 409–422.
5. [5] McWhinney, S.R., Goldberg, R.M., McLeod, H.L., Platinum neurotoxicity pharmacogenetics. Mol. Cancer. Ther. 8 (2009), 10–16.
6. [6] Rabik, C.A., Dolan, M.E., Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat. Rev. 33 (2007), 9–23.
7. [7] Peer, D., Karp, J.M., Hong, S., FaroKHzad, O.C., Margalit, R., Langer, R., Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2 (2007), 751–760.
8. [8] Sun, T.M., Zhang, Y.S., Pang, B., Hyun, D.C., Yang, M.X., Xia, Y.N., Engineered nanoparticles for drug delivery in cancer therapy. Angew. Chem. Int. Ed. 53 (2014), 12320–12364.
9. [9] Zhao, X., Li, F., Li, Y.Y., Wang, H., Ren, H., Chen, J., Nie, G.J., Hao, J.H., Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer. Biomaterials 46 (2015), 13–25.
10. [10] Xu, H.P., Cao, W., Zhang, X., Selenium-containing polymers: promising biomaterials for controlled release and enzyme mimics. Acc. Chem. Res. 46 (2013), 1647–1658.
11. [11] Cao, W., Gu, Y.W., Meineck, M., Xu, H.P., The combination of chemotherapy and radiotherapy towards more efficient drug delivery. Chem. Asian. J. 9 (2014), 48–57.
12. [12] Kwon, I.C., Bae, Y.H., Kim, S.W., Electrically credible polymer gel for controlled release of drugs. Nature 354 (1991), 291–293.
13. [13] Hu, X.L., Liu, G.H., Li, Y., Wang, X.R., Liu, S.Y., Cell-penetrating hyperbranched polyprodrug amphiphiles for synergistic reductive milieu-triggered drug release and enhanced magnetic resonance signals. J. Am. Chem. Soc. 137 (2015), 362–368.
14. [14] Li, L.Y., Raghupathi, K., Yuan, C.H., Surface charge generation in nanogels for activated cellular uptake at tumor-relevant pH. Chem. Sci. 4 (2013), 3654–3660.
15. [15] Kim, J., Pramanick, S., Lee, D., Park, H., Kim, W.J., Polymeric biomaterials for the delivery of platinum-based anticancer drugs. Biomater. Sci. 3 (2015), 1002–1017.
16. 2-responsive nanocarrier for dual-release of platinum anticancer drugs and O-2: controlled release and enhanced cytotoxicity against cisplatin resistant cancer cells. Chem. Commun. 50 (2014), 9714–9717.
17. [17] Favareto, A.P.A., Nogueira, L.C., Pontes, D.A., Mesquita, S.D.P., Camargo, I.C.C., Evaluation of testicular tissue of adult rats treated with cisplatin incorporated into the liposome. Microsc. Res. Tech. 78 (2015), 323–329.
18. [18] Min, Y.Z., Li, J.M., Liu, F., Yeow, E.K.L., Xing, B.G., Near-infrared light-mediated photoactivation of a platinum antitumor prodrug and simultaneous cellular apoptosis imaging by upconversion-luminescent nanoparticles. Angew. Chem. Int. Ed. 53 (2014), 1012–1016.
19. [19] Tang, L., Tong, R., Coyle, V.J., Yin, Q., Pondenis, H., Borst, L.B., Cheng, J., Fan, T.M., Targeting tumor vasculature with aptamer-functionalized doxorubicin-polylactide nanoconjugates for enhanced cancer therapy. ACS Nano 9 (2015), 5072–5081.
20. [20] Haxton, K.J., Burt, H.M., Polymeric drug delivery of platinum-based anticancer agents. J. Pharm. Sci. 98 (2009), 2299–2316.
21. [21] Nishiyama, N., Okazaki, S., Kataoka, K., Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res. 63 (2003), 8977–8983.
22. [22] Baba, M., Matsumoto, Y., Kashio, A., Cabral, H., Nishiyama, N., Kataoka, K., Amasoba, Y.T., Micellization of cisplatin (NC-6004) reduces its ototoxicity in Guinea pigs. J. Control. Release 157 (2012), 112–117.
23. [23] Plummer, R., Wilson, R.H., Calvert, H., Boddy, A.V., Griffin, M., Sludden, J., Tilby, M.J., Eatock, M., Pearson, D.G., Ottley, C.J., Matsumura, Y., Kataoka, K., Nishiya, T., A phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumors. Br. J. Cancer 104 (2011), 593–598.
24. [24] Schechter, B., Neumann, A., Wilchek, M., Arnon, R., Soluble polymers as carriers of cis-platinum. J. Control Release 10 (1989), 75–87.
25. [25] Liao, L.Y., Liu, J., Dreaden, E.C., Morton, S.W., Shopsowitz, K.E., Hammond, P.T., Johnson, J.A., A convergent synthetic platform for single-nanoparticle combination cancer therapy: ratiometric loading and controlled release of cisplatin, doxorubicin, and camptothecin. J. Am. Chem. Soc. 136 (2014), 5896–5899.
26. [26] Huynh, V.T., Quek, J.Y., de Souza, P.L., Stenzel, M.H., Block copolymer micelles with pendant bifunctional chelator for platinum drugs: effect of spacer length on the viability of tumor cells. Biomacromolecules 13 (2012), 1010–1023.
27. [27] Gerweck, L.E., Vijayappa, S., Kozin, S., Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics. Mol. Cancer. Ther. 5 (2006), 1275–1279.
28. [28] Zhuang, J., Gordon, M., Ventura, J., Li, L., Thayumanavan, S., Multi-stimuli responsive macromolecules and their assemblies. Chem. Soc. Rev. 42 (2013), 7421–7435.
29. [29] Yin, L.C., Tang, H.Y., Zheng, K.H.N., Song, Z.Y., Gabrielson, N.P., Lu, H., Cheng, J.J., Light-responsive helical polypeptides capable of reducing toxicity and unpacking DNA: toward nonviral gene delivery. Angew. Chem. Int. Ed. 52 (2013), 9182–9186.
30. [30] Cao, W., Gu, Y.W., Li, T.Y., Xu, H.P., Ultra-sensitive ROS-responsive tellurium-containing polymers. Chem. Commun. 51 (2015), 7069–7071.
31. [31] Fang, R.C., Xu, H.P., Cao, W., Yang, L.L., Zhang, X., Reactive oxygen species (ROS)-responsive tellurium-containing hyperbranched polymer. Polym. Chem. 6 (2015), 2817–2821.
32. [32] Wang, L., Fan, F.Q., Cao, W., Xu, H.P., Ultrasensitive ROS-pesponsive coassemblies of tellurium-containing molecules and phospholipids. ACS. Appl. Mater. Interfaces 7 (2015), 16054–16060.
33. [33] Cao, W., Wang, L., Xu, H.P., Selenium/tellurium containing polymer materials in nanobiotechnology. Nano Today 10 (2015), 717–736.
34. [34] Wang, L., Cao, W., Xu, H.P., Tellurium-containing polymers: towards biomaterials and optoelectronic materials. ChemNanoMat 2 (2016), 479–488.
35. [35] Cao, W., Wang, L., Xu, H.P., Coordination responsive tellurium-containing multilayer film for controlled delivery. Chem. Commun. 51 (2015), 5520–5522.
36. [36] Cao, W., Gu, Y.W., Meineck, M., Li, T.Y., Xu, H.P., Tellurium-containing polymer micelles: competitive-ligand-regulated coordination responsive systems. J. Am. Chem. Soc. 136 (2014), 5132–5137.
37. [37] Li, Y.Y., Wen, T., Zhao, R.F., Liu, X.X., Ji, T.J., Wang, H., Shi, X.W., Shi, J., Wei, J.Y., Zhao, Y.L., Wu, X.C., Nie, G.J., Localized electric field of plasmonic nanoplatform enhanced photodynamic tumor therapy. ACS Nano 8 (2014), 11529–11542.
38. [38] Viitala, L., Pajari, S., Lajunen, T., Kontturi, L.S., Laaksonen, T., Kuosmanen, P., Viitala, T., Urtti, A., Murtomaki, L., Photothermally triggered lipid bilayer phase transition and drug release from gold nanorod and indocyanine green encapsulated liposomes. Langmuir 32 (2016), 4554–4563.
39. [39] Wang, M., Sun, S., Neufeld, C.I., Perez-Ramirez, B., Xu, Q.B., Reactive oxygen species-responsive protein modification and its intracellular delivery for targeted cancer therapy. Angew. Chem. Int. Ed. 53 (2014), 13444–13448.
40. [40] He, S.S., Qi, Y.X., Kuang, G.Z., Zhou, D.F., Li, J.Z., Xie, Z.G., Chen, X.S., Jing, X.B., Huang, Y.B., Single-stimulus dual-drug sensitive nanoplatform for enhanced photoactivated therapy. Biomacromolecules 17 (2016), 2027–2120.
41. [41] Xu, Q.H., He, C.L., Xiao, C.S., Chen, X.S., Reactive oxygen species (ROS) responsive polymers for biomedical applications. Macromol. Biosci. 16 (2016), 635–646.
42. [42] Viger, M.L., Grossman, M., Fomina, N., Almutairi, A., Low power upconverted near-IR light for efficient polymeric nanoparticle degradation and cargo release. Adv. Mater. 25 (2013), 3733–3738.
43. [43] Mo, R., Jiang, T.Y., Sun, W.J., Gu, Z., ATP-triggered anticancer drug delivery. Nat. Commun. 50 (2014), 67–74.
44. [44] Wang, H., Wu, Y., Zhao, R.F., Nie, G.J., Engineering the assemblies of biomaterial nanocarriers for delivery of multiple theranostic agents with enhanced antitumor efficacy. Adv. Mater. 25 (2013), 1616–1622.